fda semaglutide warning news october 2025 Warns Novo Nordisk on Unreported Deaths US FDA removes suicidal thoughts

Stewart, J., BPharm

Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program

However, the growing number of lawsuits suggests this legal battle is far from over

Retatrutides glucagon receptor activity is one of the features that makes it different from tirzepatide and semaglutide

This hormone regulates appetite, slows gastric emptying, and enhances insulin secretion, all of which potentially contribute to better blood sugar control and weight loss

Although these medications can prove beneficial, theyre not a cure-all